查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1617120

2030 年研究抗體和試劑市場預測：按技術、應用、最終用戶和地區進行的全球分析

Research Antibodies and Reagents Market Forecasts to 2030 - Global Analysis By Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球研究抗體和試劑市場規模為 128.3 億美元，預計到 2030 年將達到 211.6 億美元，在預測期內複合年成長率為 8.7%。

研究抗體和試劑是科學實驗的重要工具，主要是在分子生物學、免疫學和生物化學領域。抗體是由免疫系統產生的蛋白質，專門設計用於與特異性抗原結合，對於檢測、識別和定量各種生物樣本中的蛋白質和其他分子非常有用。另一方面，研究試劑是指促進或增強實驗過程的各種物質，例如緩衝液、酵素、引子和實驗中使用的其他化學物質。這些試劑透過提供反應所需的化學環境和生物成分，幫助最佳化實驗的準確性和可靠性。

根據 CBRE Research 的數據，過去 5 年美國生命科學公司的研發支出增加了 40%，到 2021 年將達到近 1,540 億美元。

個人化醫療需求不斷成長

個人化醫療根據個人的遺傳、生活方式和特定疾病特徵量身訂做治療方案，需要準確且有針對性的診斷工具。研究性抗體對於檢測特定蛋白質和生物標記至關重要，以及支持各種實驗程序的試劑在個人化治療的進步中發揮重要作用。這些抗體和試劑用於基因檢測、生物標記發現和藥物開發，這些都是個人化醫療的基本要素。在分子層面上準確理解疾病機制的能力對於開發更有效且副作用更少的治療方法極為重要。

產品高成本

研究抗體和試劑的高成本是科學進步的主要障礙，特別是在免疫學、生物技術和藥物開發等領域。由於產量有限、品管標準和原料成本等因素，這些用於診斷、蛋白質分析和細胞研究等實驗的基本工具往往價格昂貴得令人望而卻步。許多學術機構、小型實驗室和嶄露頭角的研究人員面臨預算限制，難以獲得所需的抗體和試劑。其結果是計劃延遲、實驗範圍有限、科學進展緩慢。

增加對癌症研究的投資

對癌症研究的投資增加正在推動研究抗體和試劑的開發取得重大進展，這些抗體和試劑是在分子層面上理解和靶向癌症的重要工具。隨著癌症研究的不斷發展，資金正在幫助科學家開發更特異性、更敏感和更多樣化的抗體，提高我們檢測癌症標記和追蹤腫瘤進展的能力。這些試劑在基礎研究和臨床實踐中都很重要，有助於更深入地了解癌症生物學、確定新的治療標靶並改進診斷方法。人們對免疫療法和個人化醫療的日益關注進一步增加了對高品質抗體的需求，這些抗體可以靶向特定癌細胞，同時最大限度地減少對健康組織的損害。

品質和特異性問題

研究抗體和試劑市場面臨與品質和特異性問題相關的重大挑戰，阻礙了其科學研究的有效性。抗體對於蛋白質檢測和分析至關重要，但由於製造過程的變化和驗證不足，抗體的性能常常不一致。因此，重現性可能很差，且抗體可能與非預期目標結合，導致結果不準確。缺乏標準化的試劑配方可能會使實驗方案變得複雜，並使研究人員難以在不同實驗室之間重現結果。

COVID-19 的影響：

COVID-19 大流行對研究抗體和試劑市場產生了重大影響，擾亂了供應鏈、研究重點和製造流程。在疫情最嚴重時期，隨著許多實驗室和研究機構將重點轉向研究該病毒，對專門用於檢測和治療 COVID-19 的抗體、試劑和診斷工具的需求增加。這迫使許多研究人員透過購買替代試劑和改變研究通訊協定來適應。儘管有這些挑戰，大流行加速了抗體和試劑開發的創新，特別是在病毒檢測和疫苗研究方面。

流式細胞技術領域預計將成為預測期內最大的細分市場

預計流式細胞技術領域在預測期內將佔據最大佔有率。流式細胞技術是免疫學、細胞生物學和診斷學中的強大工具，可根據細胞的物理和化學特性對細胞進行分析和分類。增強研究抗體和試劑對於提高流式細胞技術技術的準確性和可靠性至關重要。透過開發高度特異性和最佳化的抗體，研究人員可以靶向多種細胞表面標誌物和細胞內蛋白質，從而促進複雜生物過程的研究。螢光偶聯物、緩衝液和檢測系統等試劑創新將進一步提高流式細胞技術的靈敏度、解析度和準確性。

預計藥物開發領域在預測期內複合年成長率最高。

預計藥物開發領域將在預測期內快速成長。藥物開發領域越來越注重增強研究抗體和試劑，以加速新療法的發現和開發。這些抗體和試劑在闡明疾病的潛在機制、識別潛在的藥物標靶和檢驗候選治療藥物方面發揮重要作用。提高這些工具的品質、特異性和可靠性將使研究人員能夠產生更準確和可重複的資料，這對於推進藥物發現至關重要。研究抗體的富集對於準確的生物標記檢測、細胞訊號路徑分析和體外診斷應用非常有用。

比最大的地區

預計北美地區將在整個預測期內佔據最大的市場佔有率。隨著生物技術、製藥和個人化醫療的不斷進步，對高品質抗體和試劑的需求正在迅速增加。這些工具對於標靶治療、生物標記識別和診斷的開發至關重要，特別是在癌症、自體免疫疾病和感染疾病。北美研究人員正在利用 CRISPR 和基因編輯等尖端技術，這些技術在很大程度上依賴專門的試劑和抗體。此外，製藥公司和學術機構加大研發投資也進一步加速了該地區的需求。

複合年成長率最高的地區：

據估計，歐洲地區在預測期內的複合年成長率最高。透過促進學術機構、研究機構和生物技術公司之間的合作，歐洲已成為生命科學前沿發展的中心。這些夥伴關係能夠共用專業知識、資源和技術，以加速高品質抗體和試劑的發現和最佳化。此外，與全球產業領導者的合資企業和合作確保獲得最新技術和監管見解，促進更具體、更有效的研究工具的開發。因此，歐洲研究人員受益於更廣泛的專業產品，提高了他們進行準確和有影響力的實驗的能力。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球研究抗體與試劑市場：依技術分類

  • 流式細胞技術
  • 免疫沉澱分析法
  • 蛋白質印跡法
  • 多重免疫吸附測定
  • 酵素免疫分析法
  • 其他技術

第6章 全球研究抗體與試劑市場：依應用分類

  • 藥物開發
  • 蛋白質體學
  • 基因組學

第7章 全球研究抗體與試劑市場：依最終使用者分類

  • 製藥和生物技術產業
  • 學術研究所
  • 合約研究組織

第8章全球研究抗體和試劑市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第 10 章 公司概況

  • Abcam Limited
  • Agilent Technologies, Inc
  • Bio-Rad Laboratories, Inc
  • F. Hoffmann-La Roche AG
  • GE Healthcare Life Sciences
  • Merck Group
  • OriGene Technologies
  • PerkinElmer
  • Promega Corporation
  • SAB Biotherapeutics
  • Santa Cruz Biotechnology
  • Tecan Group
  • Thermo Fisher Scientific
  • Eppendorf AG
  • Lonza Group
Product Code: SMRC27998

According to Stratistics MRC, the Global Research Antibodies and Reagents Market is accounted for $12.83 billion in 2024 and is expected to reach $21.16 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Research antibodies and reagents are essential tools in scientific experiments, primarily in the fields of molecular biology, immunology, and biochemistry. Antibodies, which are proteins produced by the immune system, are specifically designed to bind to unique antigens, making them invaluable for detecting, identifying, and quantifying proteins or other molecules in various biological samples. Research reagents, on the other hand, refer to a broad range of substances that facilitate or enhance laboratory procedures, including buffers, enzymes, primers, and other chemicals used in experiments. These reagents help optimize the accuracy and reliability of experiments by providing the necessary chemical environment or biological components for reactions to occur.

According to CBRE Research, R&D expenditures by US life sciences companies have grown by ~ 40% over the past five years to reach nearly USD 154 billion in 2021.

Market Dynamics:

Driver:

Rising demand for personalized medicine

Personalized medicine, which tailors treatments based on an individual's genetic makeup, lifestyle, and specific disease characteristics, requires precise and targeted diagnostic tools. Research antibodies, which are essential for detecting specific proteins or biomarkers, and reagents that enable various laboratory procedures, play a crucial role in advancing personalized therapies. These antibodies and reagents are utilized in the development of genetic testing, biomarker discovery, and drug development, which are integral components of personalized medicine. The ability to accurately target disease mechanisms at a molecular level is pivotal in developing treatments that are more effective and have fewer side effects.

Restraint:

High cost of products

The high cost of research antibodies and reagents is a significant barrier to scientific progress, particularly in fields like immunology, biotechnology, and drug development. These essential tools, used for experiments such as diagnostics, protein analysis, and cell research, are often prohibitively expensive due to factors like limited production, high-quality control standards, and the cost of raw materials. Many academic institutions, small labs, and emerging researchers face budget constraints, making it difficult to access the required antibodies and reagents. This results in delayed projects, limited scope of experiments, and a slowdown in scientific advancements.

Opportunity:

Increased investment in cancer research

Increased investment in cancer research is driving significant advancements in the development of research antibodies and reagents, which are essential tools for understanding and targeting cancer at the molecular level. As cancer research continues to evolve, funding has allowed scientists to develop more specific, sensitive, and diverse antibodies, enhancing their ability to detect cancer markers and track tumor progression. These reagents are critical in both basic research and clinical settings, facilitating a deeper understanding of cancer biology, identifying new therapeutic targets, and improving diagnostics. The growing focus on immunotherapy and personalized medicine has further fueled the demand for high-quality antibodies, which can target specific cancer cells while minimizing damage to healthy tissue.

Threat:

Quality and specificity issues

The research antibodies and reagents market is facing significant challenges related to quality and specificity issues, which are hampering their effectiveness in scientific studies. Antibodies, crucial for detecting and analyzing proteins, often suffer from inconsistency in performance due to variations in manufacturing processes and inadequate validation. This results in poor reproducibility, where antibodies may bind to unintended targets, leading to inaccurate results. The lack of standardization in reagent formulations complicates experimental protocols, as researchers may face difficulty replicating results across different laboratories.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the research antibodies and reagents market, disrupting supply chains, research priorities, and manufacturing processes. During the height of the pandemic, many laboratories and research institutions shifted focus toward studying the virus, which led to an increased demand for antibodies, reagents, and diagnostic tools specific to COVID-19 detection and treatment. This situation forced many researchers to adapt by sourcing alternative reagents or modifying their research protocols. Despite these challenges, the pandemic also accelerated innovations in antibody and reagent development, especially for virus detection and vaccine research, which will likely have lasting benefits for future immunological studies and diagnostics.

The Flow Cytometry segment is expected to be the largest during the forecast period

Flow Cytometry segment is expected to dominate the largest share over the estimated period. Flow cytometry is a powerful tool used in immunology, cell biology, and diagnostics to analyze and sort cells based on their physical and chemical properties. The segment focused on enhancing research antibodies and reagents is crucial for improving the precision and reliability of flow cytometry techniques. By developing highly specific and optimized antibodies, researchers can target a wide range of cell surface markers and intracellular proteins, facilitating the study of complex biological processes. Innovations in reagents, such as fluorescence conjugates, buffers, and detection systems, further enhance the sensitivity, resolution, and accuracy of flow cytometry.

The Drug Development segment is expected to have the highest CAGR during the forecast period

Drug Development segment is estimated to grow at a rapid pace during the forecast period. The drug development sector is increasingly focusing on enhancing research antibodies and reagents to accelerate the discovery and development of new therapeutics. These antibodies and reagents play a critical role in understanding the underlying mechanisms of diseases, identifying potential drug targets, and validating therapeutic candidates. By improving the quality, specificity, and reliability of these tools, researchers can generate more accurate and reproducible data, which is essential for advancing drug discovery. Enhanced research antibodies help in precise biomarker detection, cell signaling pathway analysis and in vitro diagnostic applications.

Region with largest share:

North America region is poised to hold the largest share of the market throughout the extrapolated period. With continuous advancements in biotechnology, pharmaceuticals, and personalized medicine, the demand for high-quality antibodies and reagents has surged. These tools are crucial for the development of targeted therapies, biomarker identification, and diagnostics, especially in cancer, autoimmune diseases, and infectious diseases. North American researchers are leveraging cutting-edge techniques such as CRISPR and gene editing, which rely heavily on specialized reagents and antibodies. Additionally, increasing investment in research and development by pharmaceutical companies and academic institutions is further accelerating the demand across the region.

Region with highest CAGR:

Europe region is estimated to witness the highest CAGR during the projected time frame. By fostering collaborations between academic institutions, research organizations, and biotechnology companies, Europe has become a hub for cutting-edge developments in life sciences. These partnerships enable the sharing of expertise, resources, and technologies, which accelerates the discovery and optimization of high-quality antibodies and reagents. Additionally, joint ventures and collaborations with global industry leaders ensure access to the latest technologies and regulatory insights, promoting the development of more specific and effective research tools. As a result, European researchers benefit from a wider array of specialized products, enhancing their ability to conduct precise and impactful experiments.

Key players in the market

Some of the key players in Research Antibodies and Reagents market include Abcam Limited, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche AG, GE Healthcare Life Sciences, Merck Group, OriGene Technologies, PerkinElmer, Promega Corporation, SAB Biotherapeutics, Santa Cruz Biotechnology, Tecan Group, Thermo Fisher Scientific, Eppendorf AG and Lonza Group.

Key Developments:

In August 2023, Danaher (US) entered into a definitive agreement to acquire all the outstanding shares of Abcam plc (UK). Through this development, Abcam is expected to operate as a standalone operating company within Danaher's Life Sciences segment.

In August 2023, Agilent Technologies, Inc. (US) announced the opening of a new full-scale Integrated Biology Center located at Monash University in Malaysia. The facility is focused on building local capabilities to accelerate research and development (R&D) in life science research.

Technologies Covered:

  • Flow Cytometry
  • Immunoprecipitation
  • Western Blotting
  • Multiplex Immunosorbent Assay
  • Enzyme-Linked Immunosorbent Assay
  • Other Technologies

Applications Covered:

  • Drug Development
  • Proteomics
  • Genomics

End Users Covered:

  • Pharmaceutical and Biotechnologies Industries
  • Academic and Research Institutions
  • Contract Research Organizations

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Research Antibodies and Reagents Market, By Technology

  • 5.1 Introduction
  • 5.2 Flow Cytometry
  • 5.3 Immunoprecipitation
  • 5.4 Western Blotting
  • 5.5 Multiplex Immunosorbent Assay
  • 5.6 Enzyme-Linked Immunosorbent Assay
  • 5.7 Other Technologies

6 Global Research Antibodies and Reagents Market, By Application

  • 6.1 Introduction
  • 6.2 Drug Development
  • 6.3 Proteomics
  • 6.4 Genomics

7 Global Research Antibodies and Reagents Market, By End User

  • 7.1 Introduction
  • 7.2 Pharmaceutical and Biotechnologies Industries
  • 7.3 Academic and Research Institutions
  • 7.4 Contract Research Organizations

8 Global Research Antibodies and Reagents Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abcam Limited
  • 10.2 Agilent Technologies, Inc
  • 10.3 Bio-Rad Laboratories, Inc
  • 10.4 F. Hoffmann-La Roche AG
  • 10.5 GE Healthcare Life Sciences
  • 10.6 Merck Group
  • 10.7 OriGene Technologies
  • 10.8 PerkinElmer
  • 10.9 Promega Corporation
  • 10.10 SAB Biotherapeutics
  • 10.11 Santa Cruz Biotechnology
  • 10.12 Tecan Group
  • 10.13 Thermo Fisher Scientific
  • 10.14 Eppendorf AG
  • 10.15 Lonza Group

List of Tables

  • Table 1 Global Research Antibodies and Reagents Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Research Antibodies and Reagents Market Outlook, By Technology (2022-2030) ($MN)
  • Table 3 Global Research Antibodies and Reagents Market Outlook, By Flow Cytometry (2022-2030) ($MN)
  • Table 4 Global Research Antibodies and Reagents Market Outlook, By Immunoprecipitation (2022-2030) ($MN)
  • Table 5 Global Research Antibodies and Reagents Market Outlook, By Western Blotting (2022-2030) ($MN)
  • Table 6 Global Research Antibodies and Reagents Market Outlook, By Multiplex Immunosorbent Assay (2022-2030) ($MN)
  • Table 7 Global Research Antibodies and Reagents Market Outlook, By Enzyme-Linked Immunosorbent Assay (2022-2030) ($MN)
  • Table 8 Global Research Antibodies and Reagents Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 9 Global Research Antibodies and Reagents Market Outlook, By Application (2022-2030) ($MN)
  • Table 10 Global Research Antibodies and Reagents Market Outlook, By Drug Development (2022-2030) ($MN)
  • Table 11 Global Research Antibodies and Reagents Market Outlook, By Proteomics (2022-2030) ($MN)
  • Table 12 Global Research Antibodies and Reagents Market Outlook, By Genomics (2022-2030) ($MN)
  • Table 13 Global Research Antibodies and Reagents Market Outlook, By End User (2022-2030) ($MN)
  • Table 14 Global Research Antibodies and Reagents Market Outlook, By Pharmaceutical and Biotechnologies Industries (2022-2030) ($MN)
  • Table 15 Global Research Antibodies and Reagents Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
  • Table 16 Global Research Antibodies and Reagents Market Outlook, By Contract Research Organizations (2022-2030) ($MN)
  • Table 17 North America Research Antibodies and Reagents Market Outlook, By Country (2022-2030) ($MN)
  • Table 18 North America Research Antibodies and Reagents Market Outlook, By Technology (2022-2030) ($MN)
  • Table 19 North America Research Antibodies and Reagents Market Outlook, By Flow Cytometry (2022-2030) ($MN)
  • Table 20 North America Research Antibodies and Reagents Market Outlook, By Immunoprecipitation (2022-2030) ($MN)
  • Table 21 North America Research Antibodies and Reagents Market Outlook, By Western Blotting (2022-2030) ($MN)
  • Table 22 North America Research Antibodies and Reagents Market Outlook, By Multiplex Immunosorbent Assay (2022-2030) ($MN)
  • Table 23 North America Research Antibodies and Reagents Market Outlook, By Enzyme-Linked Immunosorbent Assay (2022-2030) ($MN)
  • Table 24 North America Research Antibodies and Reagents Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 25 North America Research Antibodies and Reagents Market Outlook, By Application (2022-2030) ($MN)
  • Table 26 North America Research Antibodies and Reagents Market Outlook, By Drug Development (2022-2030) ($MN)
  • Table 27 North America Research Antibodies and Reagents Market Outlook, By Proteomics (2022-2030) ($MN)
  • Table 28 North America Research Antibodies and Reagents Market Outlook, By Genomics (2022-2030) ($MN)
  • Table 29 North America Research Antibodies and Reagents Market Outlook, By End User (2022-2030) ($MN)
  • Table 30 North America Research Antibodies and Reagents Market Outlook, By Pharmaceutical and Biotechnologies Industries (2022-2030) ($MN)
  • Table 31 North America Research Antibodies and Reagents Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
  • Table 32 North America Research Antibodies and Reagents Market Outlook, By Contract Research Organizations (2022-2030) ($MN)
  • Table 33 Europe Research Antibodies and Reagents Market Outlook, By Country (2022-2030) ($MN)
  • Table 34 Europe Research Antibodies and Reagents Market Outlook, By Technology (2022-2030) ($MN)
  • Table 35 Europe Research Antibodies and Reagents Market Outlook, By Flow Cytometry (2022-2030) ($MN)
  • Table 36 Europe Research Antibodies and Reagents Market Outlook, By Immunoprecipitation (2022-2030) ($MN)
  • Table 37 Europe Research Antibodies and Reagents Market Outlook, By Western Blotting (2022-2030) ($MN)
  • Table 38 Europe Research Antibodies and Reagents Market Outlook, By Multiplex Immunosorbent Assay (2022-2030) ($MN)
  • Table 39 Europe Research Antibodies and Reagents Market Outlook, By Enzyme-Linked Immunosorbent Assay (2022-2030) ($MN)
  • Table 40 Europe Research Antibodies and Reagents Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 41 Europe Research Antibodies and Reagents Market Outlook, By Application (2022-2030) ($MN)
  • Table 42 Europe Research Antibodies and Reagents Market Outlook, By Drug Development (2022-2030) ($MN)
  • Table 43 Europe Research Antibodies and Reagents Market Outlook, By Proteomics (2022-2030) ($MN)
  • Table 44 Europe Research Antibodies and Reagents Market Outlook, By Genomics (2022-2030) ($MN)
  • Table 45 Europe Research Antibodies and Reagents Market Outlook, By End User (2022-2030) ($MN)
  • Table 46 Europe Research Antibodies and Reagents Market Outlook, By Pharmaceutical and Biotechnologies Industries (2022-2030) ($MN)
  • Table 47 Europe Research Antibodies and Reagents Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
  • Table 48 Europe Research Antibodies and Reagents Market Outlook, By Contract Research Organizations (2022-2030) ($MN)
  • Table 49 Asia Pacific Research Antibodies and Reagents Market Outlook, By Country (2022-2030) ($MN)
  • Table 50 Asia Pacific Research Antibodies and Reagents Market Outlook, By Technology (2022-2030) ($MN)
  • Table 51 Asia Pacific Research Antibodies and Reagents Market Outlook, By Flow Cytometry (2022-2030) ($MN)
  • Table 52 Asia Pacific Research Antibodies and Reagents Market Outlook, By Immunoprecipitation (2022-2030) ($MN)
  • Table 53 Asia Pacific Research Antibodies and Reagents Market Outlook, By Western Blotting (2022-2030) ($MN)
  • Table 54 Asia Pacific Research Antibodies and Reagents Market Outlook, By Multiplex Immunosorbent Assay (2022-2030) ($MN)
  • Table 55 Asia Pacific Research Antibodies and Reagents Market Outlook, By Enzyme-Linked Immunosorbent Assay (2022-2030) ($MN)
  • Table 56 Asia Pacific Research Antibodies and Reagents Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 57 Asia Pacific Research Antibodies and Reagents Market Outlook, By Application (2022-2030) ($MN)
  • Table 58 Asia Pacific Research Antibodies and Reagents Market Outlook, By Drug Development (2022-2030) ($MN)
  • Table 59 Asia Pacific Research Antibodies and Reagents Market Outlook, By Proteomics (2022-2030) ($MN)
  • Table 60 Asia Pacific Research Antibodies and Reagents Market Outlook, By Genomics (2022-2030) ($MN)
  • Table 61 Asia Pacific Research Antibodies and Reagents Market Outlook, By End User (2022-2030) ($MN)
  • Table 62 Asia Pacific Research Antibodies and Reagents Market Outlook, By Pharmaceutical and Biotechnologies Industries (2022-2030) ($MN)
  • Table 63 Asia Pacific Research Antibodies and Reagents Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
  • Table 64 Asia Pacific Research Antibodies and Reagents Market Outlook, By Contract Research Organizations (2022-2030) ($MN)
  • Table 65 South America Research Antibodies and Reagents Market Outlook, By Country (2022-2030) ($MN)
  • Table 66 South America Research Antibodies and Reagents Market Outlook, By Technology (2022-2030) ($MN)
  • Table 67 South America Research Antibodies and Reagents Market Outlook, By Flow Cytometry (2022-2030) ($MN)
  • Table 68 South America Research Antibodies and Reagents Market Outlook, By Immunoprecipitation (2022-2030) ($MN)
  • Table 69 South America Research Antibodies and Reagents Market Outlook, By Western Blotting (2022-2030) ($MN)
  • Table 70 South America Research Antibodies and Reagents Market Outlook, By Multiplex Immunosorbent Assay (2022-2030) ($MN)
  • Table 71 South America Research Antibodies and Reagents Market Outlook, By Enzyme-Linked Immunosorbent Assay (2022-2030) ($MN)
  • Table 72 South America Research Antibodies and Reagents Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 73 South America Research Antibodies and Reagents Market Outlook, By Application (2022-2030) ($MN)
  • Table 74 South America Research Antibodies and Reagents Market Outlook, By Drug Development (2022-2030) ($MN)
  • Table 75 South America Research Antibodies and Reagents Market Outlook, By Proteomics (2022-2030) ($MN)
  • Table 76 South America Research Antibodies and Reagents Market Outlook, By Genomics (2022-2030) ($MN)
  • Table 77 South America Research Antibodies and Reagents Market Outlook, By End User (2022-2030) ($MN)
  • Table 78 South America Research Antibodies and Reagents Market Outlook, By Pharmaceutical and Biotechnologies Industries (2022-2030) ($MN)
  • Table 79 South America Research Antibodies and Reagents Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
  • Table 80 South America Research Antibodies and Reagents Market Outlook, By Contract Research Organizations (2022-2030) ($MN)
  • Table 81 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Country (2022-2030) ($MN)
  • Table 82 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Technology (2022-2030) ($MN)
  • Table 83 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Flow Cytometry (2022-2030) ($MN)
  • Table 84 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Immunoprecipitation (2022-2030) ($MN)
  • Table 85 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Western Blotting (2022-2030) ($MN)
  • Table 86 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Multiplex Immunosorbent Assay (2022-2030) ($MN)
  • Table 87 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Enzyme-Linked Immunosorbent Assay (2022-2030) ($MN)
  • Table 88 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 89 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Application (2022-2030) ($MN)
  • Table 90 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Drug Development (2022-2030) ($MN)
  • Table 91 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Proteomics (2022-2030) ($MN)
  • Table 92 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Genomics (2022-2030) ($MN)
  • Table 93 Middle East & Africa Research Antibodies and Reagents Market Outlook, By End User (2022-2030) ($MN)
  • Table 94 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Pharmaceutical and Biotechnologies Industries (2022-2030) ($MN)
  • Table 95 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
  • Table 96 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Contract Research Organizations (2022-2030) ($MN)